Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Compe
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company DecisionEckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG 20.10.2023 / 15:40 CET/CESTThe issuer is solely responsible for the cont...
Source: pharmiweb.com